145 related articles for article (PubMed ID: 25249770)
1. Gender-dependent association of HSD11B1 single nucleotide polymorphisms with glucose and HDL-C levels.
Turek LV; Leite N; Rodrigues Souza RL; Lima JK; Milano GE; Timossi Lda S; Osiecki AC; Osiecki R; Alle LF
Genet Mol Biol; 2014 Sep; 37(3):490-5. PubMed ID: 25249770
[TBL] [Abstract][Full Text] [Related]
2. Role of 11β HSD 1, rs12086634, and rs846910 single-nucleotide polymorphisms in metabolic-related skin diseases: a clinical, biochemical, and genetic study.
Farag AGA; Badr EA; Eltorgoman AMA; Assar MF; Elshafey EN; Tayel NR; Aboutaleb HE
Clin Cosmet Investig Dermatol; 2019; 12():91-102. PubMed ID: 30774405
[TBL] [Abstract][Full Text] [Related]
3. Association of HSD11B1 gene polymorphisms with type 2 diabetes and metabolic syndrome in South Indian population.
Devang N; Satyamoorthy K; Rai PS; Nandini M; Rao S; Phani NM; Adhikari P
Diabetes Res Clin Pract; 2017 Sep; 131():142-148. PubMed ID: 28750217
[TBL] [Abstract][Full Text] [Related]
4. A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome.
Gambineri A; Tomassoni F; Munarini A; Stimson RH; Mioni R; Pagotto U; Chapman KE; Andrew R; Mantovani V; Pasquali R; Walker BR
Eur J Endocrinol; 2011 Aug; 165(2):283-92. PubMed ID: 21622477
[TBL] [Abstract][Full Text] [Related]
5. Association between Selected Polymorphisms rs12086634, rs846910, rs4844880, rs3753519 of 11β-Hydroxysteroid Dehydrogenase Type 1 (
Szweda-Gandor N; Śnit M; Grzeszczak W
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639470
[TBL] [Abstract][Full Text] [Related]
6. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.
Quteineh L; Vandenberghe F; Saigi Morgui N; Delacrétaz A; Choong E; Gholam-Rezaee M; Magistretti P; Bondolfi G; Von Gunten A; Preisig M; Castelao E; Vollenweider P; Waeber G; Bochud M; Kutalik Z; Conus P; Eap CB
Pharmacogenet Genomics; 2015 May; 25(5):246-58. PubMed ID: 25751397
[TBL] [Abstract][Full Text] [Related]
7. Association between 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in Bosnian population.
Dujic T; Bego T; Mlinar B; Semiz S; Malenica M; Prnjavorac B; Ostanek B; Marc J; Causevic A
Biochem Med (Zagreb); 2012; 22(1):76-85. PubMed ID: 22384521
[TBL] [Abstract][Full Text] [Related]
8. Association between a 11β-hydroxysteroid dehydrogenase type 1 gene polymorphism and metabolic syndrome in a South Indian population.
Gandhi K; Adhikari P; Basu A; Achappa B
Metab Syndr Relat Disord; 2013 Dec; 11(6):397-402. PubMed ID: 23869418
[TBL] [Abstract][Full Text] [Related]
9. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.
Nair S; Lee YH; Lindsay RS; Walker BR; Tataranni PA; Bogardus C; Baier LJ; Permana PA
Diabetologia; 2004 Jun; 47(6):1088-95. PubMed ID: 15156315
[TBL] [Abstract][Full Text] [Related]
10. Common variation at the 11-β hydroxysteroid dehydrogenase type 1 gene is associated with left ventricular mass.
Rahman TJ; Mayosi BM; Hall D; Avery PJ; Stewart PM; Connell JM; Watkins H; Keavney B
Circ Cardiovasc Genet; 2011 Apr; 4(2):156-62. PubMed ID: 21402901
[TBL] [Abstract][Full Text] [Related]
11. Genetic Variation in the 11β-hydroxysteroid-dehydrogenase 1 Gene Determines NAFLD and Visceral Obesity.
Lutz SZ; Peter A; Machicao F; Lamprinou A; Machann J; Schick F; Königsrainer I; Königsrainer A; Fritsche A; Staiger H; Häring HU; Stefan N; Kantartzis K
J Clin Endocrinol Metab; 2016 Dec; 101(12):4743-4751. PubMed ID: 27715400
[TBL] [Abstract][Full Text] [Related]
12. Relationship of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase gene polymorphisms with metabolic syndrome and type 2 diabetes.
Moon SS; Lee YS; Kim JG; Kim SW; Jeong JY; Jeon EJ; Seo HA; Kwak SH; Park KS; Lee IK
Endocr J; 2011; 58(11):949-59. PubMed ID: 21869537
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.
Gambineri A; Vicennati V; Genghini S; Tomassoni F; Pagotto U; Pasquali R; Walker BR
J Clin Endocrinol Metab; 2006 Jun; 91(6):2295-302. PubMed ID: 16551740
[TBL] [Abstract][Full Text] [Related]
14. A gene variant of 11β-hydroxysteroid dehydrogenase type 1 is associated with obesity in children.
Olza J; Gil-Campos M; Leis R; Rupérez AI; Tojo R; Cañete R; Gil A; Aguilera CM
Int J Obes (Lond); 2012 Dec; 36(12):1558-63. PubMed ID: 22310475
[TBL] [Abstract][Full Text] [Related]
15. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism.
Draper N; Echwald SM; Lavery GG; Walker EA; Fraser R; Davies E; Sørensen TI; Astrup A; Adamski J; Hewison M; Connell JM; Pedersen O; Stewart PM
J Clin Endocrinol Metab; 2002 Nov; 87(11):4984-90. PubMed ID: 12414862
[TBL] [Abstract][Full Text] [Related]
16. The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women.
Feldman K; Szappanos A; Butz H; Grolmusz V; Majnik J; Likó I; Kriszt B; Lakatos P; Tóth M; Rácz K; Patócs A
Steroids; 2012 Nov; 77(13):1345-51. PubMed ID: 22986073
[TBL] [Abstract][Full Text] [Related]
17. HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia.
Hwang JY; Lee SH; Kim GS; Koh JM; Go MJ; Kim YJ; Kim HC; Kim TH; Hong JM; Park EK; Lee JY; Kim SY
Bone; 2009 Dec; 45(6):1098-103. PubMed ID: 19651257
[TBL] [Abstract][Full Text] [Related]
18. Regulatory effect of common promoter polymorphisms on the expression of the 11beta-hydroxysteroid dehydrogenase type 1 gene.
Ku YH; Koo BK; Kwak SH; Cho YM; Shin HD; Lee HK; Kim Y; Choi JW; Oh B; Park KS
Horm Res; 2009; 72(1):25-32. PubMed ID: 19571556
[TBL] [Abstract][Full Text] [Related]
19. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
